4 weeks Coherus BioSciences, Inc. (NASDAQ:CHRS) Given Consensus Rating of “Moderate Buy” by BrokeragesMarketBeat
Shares of Coherus BioSciences, Inc. (NASDAQ:CHRS – Get Free Report) have been assigned a consensus recommendation of “Moderate Buy” from the five ratings firms that are covering the firm, Marketbeat Ratings reports. Two equities research analysts have…
X